Spinal Tech

Private Equity Firm to Purchase Johnson & Johnson Ortho-Clinical Business for $4.15B

Carlyle Group, a private equity firm, has agreed to purchase Johnson & Johnson’s ortho-clinical testing business for $4.15 billion, according to a Mass Device report.

Heather Linder

Friday, January 17th, 2014

The diagnostics business works with screening, monitoring and identifying diseases. Carlyle plans to expand the business into emerging and established markets.

More Articles on Devices:
Aurora Spine Earns Nearly $10M in Private Placement of Common Shares
Tegra Medical Names J. Mark King as CEO
Stan Janosz Joins Phillips Precision Medicraft as Director of Continuous Improvement

Next Up in Spinal Tech

Where Globus Medical stands ahead of 2026

Globus Medical went into 2025 with a strong foothold in spine and orthopedics, and it’s well-positioned for the next year.…

By: Carly Behm
Tuesday, December 23rd, 2025
Where AI 'actually makes a difference' in spine care: Dr. David Skaggs

AI in spine care has been commonly leveraged to support administrative tasks, but one of its real potentials lies in…

By: Carly Behm
Wednesday, November 19th, 2025
Stryker net sales up 10.3% in Q3: 5 notes

Medtech company Stryker reported sales increases across multiple portfolios in the third quarter, according to financial results posted Oct. 30.…

By: Ariana Portalatin
Friday, October 31st, 2025

Comments are closed.

From repetitive to real-time: AI that lightens the back-office load

Next Up in Spinal Tech

Where Globus Medical stands ahead of 2026

Where AI 'actually makes a difference' in spine care: Dr. David Skaggs

Stryker net sales up 10.3% in Q3: 5 notes

Join the spine leaders & surgeons who start their day with Becker's